A Comparison of the Safety and Efficacy of Two Different Regimens of Levofloxacin in the Treatment of Acute Bacterial Sinusitis(Sinus Infection) in Adults.
Information source: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Sinusitis
Intervention: levofloxacin (Drug)
Phase: Phase 3
Status: Completed
Sponsored by: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Official(s) and/or principal investigator(s): Johnson & Johnson Pharmaceutical Research and Development, L.L.C. Clinical Trial, Study Director, Affiliation: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Summary
The purpose of this study is to evaluate the effectiveness and safety of two antibiotic
regimens in the treatment of acute bacterial sinusitis (sinus infection) in non-hospitalized
adult patients. A 5-day course of 750 milligrams of levofloxacin given by mouth once daily
will be compared to a 10-day course of 500 milligrams of levofloxacin given by mouth once
daily.
Clinical Details
Official title: A Multicenter, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Levofloxacin 750 mg Once Daily for 5 Days Versus Levofloxacin 500 mg Once Daily for 10 Days in the Treatment of Acute Bacterial Sinusitis in Adults.
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Primary outcome: Clinical success (resolution of patient signs and symptoms) at the post-therapy visit.
Secondary outcome: Microbiologic response at the post-therapy visit and safety evaluations.
Detailed description:
When treating sinus infections (sinusitis) caused by bacteria, the traditional duration of
therapy is between 10 and 14 days. In this randomized, double-blind study, 5 days of 750
milligrams of levofloxacin given once daily will be compared to 10 days of 500 milligrams of
levofloxacin in the treatment of non-hospitalized adult patients who have acute bacterial
sinusitis. To prevent the study doctor, study staff and patients from knowing which study
drug they are taking, all study drug will manufactured to look the same and patients on the
5-day regimen will be given placebo for the last 5 days of their participation in the study.
Patients will have a sinus specimen collected at the first visit. Safety evaluations will be
conducted. The objective of the study is to demonstrate that, in the treatment of acute
bacterial sinus infections, a 5-day course of 750 milligrams of levofloxacin given once
daily is at least as effective as a 10-day course of 500 milligrams of levofloxacin given
once daily and is well tolerated.
Patients will take by mouth 750 milligrams levofloxacin capsules once daily for 5 days
followed by placebo capsules once daily for 5 days, or 500 milligrams levofloxacin capsules
once daily for 10 days.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Diagnosis of acute bacterial sinusitis, defined by clinical signs and symptoms
lasting for less than 28 days and the presence of visible nasal infection, and
confirmed by computed tomography (CT) or standard sinus x-rays
- Two or fewer episodes of bacterial sinusitis within the preceding 12 months
- Willing to undergo maxillary sinus puncture or endoscopy
Exclusion Criteria:
- Chronic sinusitis
- Use of systemic antibiotics within the past 72 hours
- Presence or history of serious complications of sinusitis
- Surgery for treating sinusitis
- Required daily use of more than 20 milligrams of prednisone (oral steroid)
- Cystic fibrosis
Locations and Contacts
Additional Information
A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Levofloxacin 750 mg Once Daily for 5 Days Versus Levofloxacin 500 mg Once Daily for 10 days in the Treatment of Acute Bacterial Sinusitis in Adults
Starting date: October 2002
Last updated: June 8, 2011
|